GSDP Norms Proposed for Inclusion in the Drugs Rules, 1945
The Health Ministry has proposed writing Good Storage and Distribution Practices into the Drugs Rules, 1945, to guard medicine quality up to the patient.

Why in News
The Union Ministry of Health and Family Welfare has proposed incorporating Good Storage and Distribution Practices guidelines for pharmaceutical products into the Drugs Rules, 1945, so that medicine quality is maintained from the manufacturer to the patient.
The Union Ministry of Health and Family Welfare has proposed that Good Storage and Distribution Practices (GSDP) guidelines for pharmaceutical products be written into the Drugs Rules, 1945. The aim is to hold the quality, safety, efficacy and integrity of medicines steady through the whole distribution chain, from the manufacturer or importer right up to the point where the product is supplied to the patient.
Where the framework comes from
The proposed framework rests on the GSDP guidance already developed by the Central Drugs Standard Control Organisation (CDSCO), the country's central drug regulator. The guidelines seek to protect the quality and identity of a medicine at every stage of distribution, and they cover procurement, purchasing, storage, distribution, transportation, documentation and record-keeping.
The risks it addresses
Keeping medicines in the right storage and transport conditions matters because quality built at the manufacturing stage can still be lost afterwards. The framework is aimed at risks that arise while products are handled and moved:
- Deterioration of the product and contamination
- Mix-ups between products in storage or transit
- Falsification of medicines
- Diversion and unauthorised distribution
What changes for the trade
Bringing GSDP requirements into the rules is expected to tighten the regulatory framework over pharmaceutical distribution and to help the central and state drug-control authorities with oversight, inspection and enforcement. It is also expected to push sturdier documentation, record-keeping and traceability, and to fix accountability on manufacturers, importers, wholesalers, distributors, stockists and others in the chain. The ministry describes the amendment as a step towards strengthening India's pharmaceutical quality-management system, so that the quality established in the factory survives until the medicine reaches the patient or the healthcare provider.
How to comment
Stakeholders and members of the public may send objections and suggestions to the Under Secretary (Drugs Regulation) in the Ministry of Health and Family Welfare at Kartavya Bhawan-1, New Delhi 110001, or by email to the ministry's drugs division. The official gazette carrying the draft can be read on the e-gazette portal. For an examination, the useful chain is the regulator (CDSCO), the rules being amended (of 1945), the practice being added (storage and distribution), and the entities made answerable under it.
Important Facts
| Proposed by | Union Ministry of Health and Family Welfare |
|---|---|
| What is proposed | Good Storage and Distribution Practices (GSDP) guidelines |
| Rules amended | Drugs Rules, 1945 |
| Guidance source | Central Drugs Standard Control Organisation (CDSCO) |
| Stages covered | Procurement, purchasing, storage, distribution, transportation, documentation and record-keeping |
| Risks addressed | Deterioration, contamination, mix-ups, falsification, diversion and unauthorised distribution |
| Accountable entities | Manufacturers, importers, wholesalers, distributors and stockists |
| Comments to | Under Secretary (Drugs Regulation), Kartavya Bhawan-1, New Delhi 110001 |
Exam Point of View
Remember the practice being added (Good Storage and Distribution Practices), the rules being amended (Drugs Rules, 1945), the regulator whose guidance it builds on (CDSCO), the stages covered in the distribution chain, and the entities made accountable.
Practice Questions
In the Health Ministry's proposal on pharmaceutical distribution, what does GSDP stand for?
- A.Generic Scheduled Drug Pricing
- B.Good Storage and Distribution Practices
- C.Government Supply and Dispensing Protocol
- D.Global Standards for Drug Packaging
Show answer
The ministry has proposed that these guidelines for pharmaceutical products be incorporated into the Drugs Rules so that the quality, safety, efficacy and integrity of medicines are maintained across the distribution chain, from the manufacturer or importer to the point of supply to the patient.
Read the full explanation →The proposed GSDP framework builds upon guidance developed by which organisation?
- A.National Pharmaceutical Pricing Authority
- B.Indian Council of Medical Research
- C.Central Drugs Standard Control Organisation
- D.Food Safety and Standards Authority of India
Show answer
The correct answer is the Central Drugs Standard Control Organisation, the central drug regulator whose guidance on storage and distribution practice forms the base of the proposed framework.
Read the full explanation →Which of the following risks is the proposed GSDP framework meant to address?
- A.Falsification and diversion of medicines
- B.Shortage of hospital beds
- C.Overpricing of patented drugs
- D.Shortfall in medical seats
Show answer
The framework is aimed at the risks that arise while pharmaceutical products are handled and moved across the supply chain, and these include deterioration, contamination, mix-ups, falsification, diversion and unauthorised distribution.
Read the full explanation →Frequently Asked Questions
What does GSDP stand for in the proposed amendment?
Good Storage and Distribution Practices. The Union Health Ministry has proposed writing these guidelines for pharmaceutical products into the Drugs Rules, 1945, so that quality and integrity are maintained from the manufacturer or importer to the patient.
Whose guidance does the proposed GSDP framework build upon?
The GSDP guidance developed by the Central Drugs Standard Control Organisation. The guidelines seek to ensure the quality and identity of medicines at every stage, covering procurement, purchasing, storage, distribution, transportation and record-keeping.
Who will be made accountable under the proposed framework?
Manufacturers, importers, wholesalers, distributors, stockists and other entities involved in distribution. The change is also meant to help central and state drug-control authorities with oversight, inspection and enforcement, and to improve traceability.
Sources
- https://www.pib.gov.in/PressReleasePage.aspx?PRID=2338316 (opens in a new tab) — Press Information Bureau
Current Affairs 19 November 2026
- Antimicrobials to Be Treated as New Drugs Under NDCT RulesNational
- Separate Wholesale Licence Proposed for Bulk Drugs in IndiaNational
- SVANidhi Samman Awards 2026 to Honour Street Vendor WorkGovernment Schemes
- CSIR Transfers Bio-Bitumen and UHPC Road Technologies to IndustryScience & Technology
- CMOT Brings 100 Young Film Talents to 57th IFFI in GoaNational
- CSIR-TKDL and IKS Division Sign MoU on Traditional KnowledgeNational
- BHASHINI Shows Voice-First Language AI at Dakshin Day 2026Science & Technology
- IAF Signs MoU With Central Sanskrit University for Yoga CoursesDefence
Related Current Affairs
- National
Gadkari Addresses 85th Indian Roads Congress Session at Hyderabad
19 November 2026 · 2 min read
Related GK
- Famous Personalities of Rajasthan: Exam Notes
28 October 2026 · Rajasthan
- Districts and Divisions of Rajasthan: Exam Notes
28 October 2026 · Rajasthan
- Tourism and World Heritage Sites of Rajasthan Notes
27 October 2026 · Rajasthan
Take the Quiz
- Current Affairs Quiz
State Exams Current Affairs Quiz: 19 November 2026
25 questions25 minutesStart Quiz





